-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Disparities in DLBCL Risk and Outcomes

Program: Scientific Workshops @ ASH
Session: Disparities in Malignant Hematology
Thursday, December 3, 2020, 2:05 PM-3:30 PM

Christopher Flowers, MD, MS

Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Disclosures: No relevant conflicts of interest to declare.